Authored By: Sarah
11 Jul 2024

 Stem Cell Banking Market Size to grow by USD 8.23 billion between 2024-2028

According to a research report “ Stem Cell Banking Market” by Product Type (Adult stem cells, Umbilical cord blood stem cells, Embryonic stem cells) Type (Private, Public) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 8.23 billion, at a CAGR of  11.65% during the forecast period. The stem cell banking market faces significant challenges for research institutions and small vendors due to the high costs associated with stem cell therapy research and clinical trials. However, government organizations have recognized the potential of stem cell research and have increased funding. In the US, the National Institutes of Health (NIH) and the California Institute of Regenerative Medicine (CIRM) are major contributors, investing approximately USD1.6 billion and USD3 billion respectively in 2019. The NIH is particularly focused on studies utilizing induced pluripotent stem cell (iPSC) technology for disease mechanism research, particularly in age-related macular degeneration.

Browse market data tables, figures, and in-depth TOC on “Stem Cell Banking Market” by Product Type (Adult stem cells, Umbilical cord blood stem cells, Embryonic stem cells) Type (Private, Public) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample


By Product Type, the Adult stem cells segment is projected to dominate the market size in 2024

In today's proactive healthcare landscape, private stem cell banks offer businesses an innovative solution for individuals and families seeking to secure their health futures. These banks enable customers to store their own or their newborn's stem cells, typically derived from umbilical cord blood, for potential medical applications. This personalized healthcare approach resonates with a wide demographic, from adults focusing on long-term wellness to expectant parents safeguarding their child's health. The value proposition of private stem cell banking lies in the peace of mind derived from possessing and controlling a valuable biological asset, serving as a form of biological insurance.

By Type, Private  segment is expected to hold the largest market size for the year 2024

In the realm of regenerative medicine, the adult stem cell segment dominates the Stem Cell Banking Market due to the ease of harvesting these cells from various developed tissues within the human body, such as the heart, brain, and kidney. Adult stem cells hold significant advantages over other types, including high acceptance in the human body, effectiveness in tissue regeneration, and rapid migration to sites of inflammation, triggering the immune system for improved healing. However, limitations in human leukocyte antigen (HLA) compatibility for procedures like bone marrow transplantations pose challenges to the widespread adoption of adult stem cells.

North America is forecasted to hold the largest market size by region in 2024

The North American region dominates the global stem cell banking market, accounting for a significant revenue share. This can be attributed to the region's advanced technological infrastructure and the presence of numerous established vendors offering stem cell storage and processing services. The US and Canada, in particular, are major contributors to the region's revenue growth. Factors such as a well-established healthcare system and the presence of over 6,600 active biotechnology companies in the US facilitate market penetration for stem cell banking providers. These companies leverage the region's advanced healthcare landscape to develop treatments for diseases like cancer using stem cells.

The Stem Cell Banking Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • AMS Biotechnology Europe Ltd.
  • CellSave Arabia FZ LLC
  • Cordlife Group Ltd.
  • CordVida
  • Cryo Cell International Inc.
  • Cryo Stemcell
  • Cryoviva Biotech Pvt. Ltd.
  • FUJIFILM Corp.
  • Global Cord Blood Corp.
  • Kids Clinic India Pvt. Ltd.
  • LifeCell International Pvt. Ltd.
  • MEDIPOST Co. Ltd.
  • New England Cord Blood Bank Inc.
  • PerkinElmer Inc.
  • Plus Therapeutics Inc.
  • ReeLabs Pvt. Ltd.
  • Regenerative Medical Services Pvt. Ltd.
  • Smart Cells International Ltd.
  • StemCyte India Therapeutics Pvt. Ltd.
  • Vita 34 International AG

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Stem Cell Banking Market is witnessing significant growth due to the increasing prevalence of cardiovascular conditions, chronic diseases, and neurodegenerative conditions in the aging population. Stem cell research holds immense potential for personalized medicine, offering therapeutic options for various diseases, including leukemia. Stem cells, these tiny cells, have the unique ability to transform into different cell types, making them valuable for regenerative medicine. Stem cell banking involves the collection, processing, cryogenically freezing, and storage of stem cells derived from adult tissues such as dental pulp, adipose tissue, and bone marrow, as well as placental stem cells. The mechanism of stem cell transplants involves transferring these cells to replace or repair damaged cells or tissues. However, immune rejection is a significant challenge in stem cell therapy. The operational costs of stem cell banking are high due to the complex process involved in collecting, processing, and storing these cells. Despite the challenges, the potential benefits of stem cell banking make it an essential area of research and development. Stem cell banks play a crucial role in providing therapeutic options for various conditions, offering hope for millions of people worldwide.

Market Research Overview

The Stem Cell Banking Market is a significant segment of the healthcare industry, representing "biological insurance" for various diseases and disorders. Healthcare providers collect and store stem cells, including peripheral blood, somatic cells, and tissue-specific stem cells, from adults and umbilical cord blood as biological assets. These samples serve as potential therapeutic options for conditions such as diabetes, cancer, cardiovascular diseases, neurological disorders like Parkinson's and Alzheimer's, and autoimmune disorders. Stem cell research continues to grow, with clinical trials exploring the regenerative potential of stem cells for leukemia, lymphomas, and other immunological, metabolic, and genetic issues. Ethical discussions surround the use of embryonic stem cells, which require the destruction of embryos, while adult stem cells from non-controversial sources like bone marrow, adipose tissue, and dental pulp are gaining popularity. Stem cell banking involves sample processing, analysis, and cryogenic storage. Biotechnology specialists and doctors are working together to develop novel technology for in situ generation, self-renewal, and transfer of stem cells for repair and replacement. The aging population and the increasing prevalence of chronic diseases have fueled the demand for stem cell banking, making it a vital component of personalized medicine and regenerative medicine. Despite the benefits, stem cell banking faces operational costs, ethical issues, and public-private investments. The mechanism of stem cell therapies and transplants is still under exploration, with patents and technological advancements playing a crucial role in their development. As awareness grows, the consumer base for stem cell banking is expanding, offering new therapeutic options for various illnesses and injuries.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!